Abstract-Pregnancy-induced hypertension m women 1s associated with severe vasoconstrlctlon and reductions m organ blood flow and cardiac output Recent studies have mdlcated that mtnc oxide (NO) synthesis mhlbltlon durmg mid to late gestation m pregnant rats results m severe hypertension and protemuna The purpose of this study was to determme the systemic hemodynamlc and regonal blood flow alterations associated with chronic NO synthesis mhlbltlon m the pregnant rat The study was conducted m four groups of rats virgin rats (n=6), pregnant rats (n=lO), vlrgm rats treated with L-NAME (n=6), and pregnant rats treated with L-NAME (n=l 1) Rats were treated with L-NAME m drmkmg water at a dose of 1 mg/d for a week startmg from day 13 of gestation m pregnant rats or an equivalent time for vlrgms Mean arterial pressure (MAP), cardiac output, total penpheral resistance (TPR), and regional flows were measured by tracmg radlolabeled mlcrospheres m conscious rats Pregnant rats that were given L-NAME showed significantly higher MAP (137+6 versus 96?2 mm Hg), higher TPR (5 08?0 58 versus 2 9020 44 mm Hg/mL/mm/lOO g), and lower cardiac output (87 4?8 4 versus 113 32 11 1 mL/mm) than pregnant controls Chronic NO synthesis mhlbltlon decreased the renal blood flow m pregnant rats at a slgmficantly greater magmtude than m vlrgm rats Significant reductions m reglonal blood flow to the heart, lungs, hver, diaphragm, and skeletal muscles were also observed m pregnant rats treated with L-NAME
D unrig normal pregnancy, maternal blood volume increases markedly, leading to approximately a 30% to 60% increase in cardiac output ' The blood pressure falls despite the increase m cardiac output, mostly because of decreased systemic vascular resistance ' Gestation m humans as well as m different animal models 1s also associated with slgmficant changes m blood flow to different organs and tissues Changes m renal hemodynamlcs include a 20% to 40% increase m GFR that has been correlated with increased RPF 3 Dramatic increases m uteroplacental blood flow also occur during pregnancy to accommodate the Increasing needs of the growing fetus 4-h Furthermore, the pressor responses to exogenously admmlstered vasoconstnctors such as norepmephrme and angotensin-11 are attenuated m pregnant rats',' and humans ' Recent studies have provided evidence that total body NO production as well as regonal production m certain vascular beds 1s increased dunng pregnancy, mdlcatmg that NO could play a role m medlatmg the attenuated vascular reactlvlty and vasodilation durmg gestation " However, the role of NO m mediating the increased cardiac output, decreased vascular resistance, and regional blood flow alterations during pregnancy has not been elucidated PIH, on the other hand, 1s characterized by increased systemic vascular resistance, contracted blood volume, enhanced senslnvlty to vasopressor agents, altered renal hemodynamics, and vascular endothehal cell damage " Although the exact mechanism responsible for PIH 1s unclear, there 1s substantial evidence that maternal vascular endothehal cell dysfunction could be involved " I3 Because NO IS thought to play an Important role m the control of arterial pressure and regional blood flow m nonpregnant animals, and since Its levels have been reported to be elevated during pregnancy, decreased NO production has been proposed to contribute to the pathogenesls of PIH '" l4 I5 Recent studies have Indicated that chrome admmlstratlon of NO synthecls inhibitors during mid to late gestation m rats leads to the development of hypertension and protemuna that returned to prepregnant levels after delivery, a result suggesting a potential model that may numlc human preeclampsla.'"-'* However, the hemodynamlc and regional blood flow alterations m this rat model of PIH have not been fully characterized
The aim of this study was to determine the systemic hemodynamlc and regional flow changes during normal pregnancy and in a rat model of PIH caused by chronic NO
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Regonal Flow m Pregnancy-Induced Hypertension Selected Abbreviations and Acronyms and flushed with 0 6 mL of salme over a period of ~20 seconds The withdrawal pump was adJusted to collect a l-mL blood sample from the femoral artery over a period of 90 seconds starting at the same time as the mlcrosphere mJectlon
Cardiac Output and Regional Flow Measurements
At the end of the expenment, rats were euthamzed by mtraventncular mJectlon of pentobarbltal Indlvldual placentas, uterus, heart, lungs, liver, stomach, intestines, ludneys, brain, and a tissue sample from the skeletal muscle of the forelimbs and hmdhmbs were carefully separated and weighed
The arterial reference sample, along with tissues and organs, were counted m a gamma counter that was set at the photopeak of the Isotope that was used The residual activity m the microsphere mJectlon coil and plugs was determmed and subtracted from the radloactlvlty ofthe co11 before mJectlon for calculation of the net amount of radloactlvlty that was mfused m each rat Pregnant rats that were gwen L-NAME showed slgmficantly higher MAP (137?6 versus 96?2 mm Hg, P< 01), higher TPR (5 0820 58 versus 2 90tO 44 mm Hg/mL/mm/lOO g, P< 05), and lower cardiac output (87 428 4 versus 113 3211 1 mL/mm, P< 05) On the other hand, the changes m MAP and cardiac output m L-NAMEtreated vlrgm rats were not statlstlcally slgmficant m comparison wth control vngm rats However, TPR was hgher (3 3020 44 versus 4 7t-0 60 mm Hg/mL/mm/lOO g, P< 05) m vugm rats that were treated mth L-NAME compared urith vugm controls Changes in Regional Hemodynamics in Virgin and Pregnant Rats in Response to Chronic NO Synthesis Inhibition   Fig 2 dustrates the renal hemodynarmc changes m vqm and pregnant rats and m vlrgm and pregnant rats treated urlth L-NAME! for 1 week RBF m pregnant rats was 44% higher (14 59?3 92 versus 10 I+1 29 mL/mm) and RVR was 12% lower (IO 33 -+ 1 62 versus 1173 If: 1 70 mm Hg/mL/mm) than m vlrgm rats However, the renal hemodynarmcs m vngm and pregnant rats were not stahstlcally different In L-NAME-treated pregnant rats, RBF was sq@icantly lower (6 06?0 83 versus 14 5923 92 n&/mm, P< 01) and RVR was slgmficantly higher (28 2523 61 versus 10 332162 mm Hg/mL/mm, P< 01) compared wth pregnant controls On the other hand, RBF m L-NAME-treated vlrgm rats was not statistically &fferent from that m vlrgm controls despite the increase m RVR Table 1 shows the regional blood flow (mL/mm/g) ( with rats treated with L-NAME weight) (Table IB) m different vascular beds (other than reproductive organs) m vlrgm and pregnant rats and m those chronically treated with L-NAME Chronic mhlbltlon of NO synthesis m virgin rats led to a slgmficant (P-C 01) decrease m pulmonary blood flow with no significant effects on blood flow to other vascular beds However, m pregnant rats chronically treated with L-NAME, slgmficant reductions m blood flow occurred m a wide variety of vascular beds, including heart, lungs, liver, and skeletal muscles (PC 05) Table 2 shows the reglonal blood flow (mL/mm) and vascular resistance (mm Hg/mL/mm) m the uterus, ovary, and placenta m each group of rats Pregnancy was associated with a 17-fold increase m uterine flow and a 22-fold decrease m utenne vascular resistance Ovanan blood flow was also slgmficantly higher and resistance was slgmficantly lower m pregnant rats than m vlrgm rats and was not significantly altered m response to chrome NO synthesis mhlbltlon m both groups Utenne and placental flows m pregnant rats that were chronically treated with L-NAME were not statlstlcally dlfferent from its values m the control pregnant group whether the data are expressed m total flow or flow per fetus
Discussion
The mam finding m this study IS that chronic NO synthesis mhlbltlon durmg mid to late gestation m rats caused a significant increase m arterial pressure associated with a slgmflcant reduction m cardiac output, increased TPR, and reduction m blood flow to different vascular beds such as the kidneys, heart, lungs, liver, and skeletal muscles Moreover, the hemodynamlc alterations m vlrgm rats treated with the same dose of L-NAME for the same penod of time either were not observed or were significantly less than those observed m pregnant rats Reglonal Flow m Pregnancy-Induced Hypertemon The data presented herem indicate that NO may play an important role m mediating the high-output, low-resistance, low-pressure state that 1s a hallmark of rat gestation Nathan et al' recently reported that m ganglion-blocked pregnant rats, mhlbltlon of NO synthesis led to an increase m artenal pressure that was slgmficantly greater m late pregnant rats than m nonpregnant rats Molnar et alI8 slmllarly observed a greater increase m blood pressure m pregnant rats given L-NAME chronically durmg late gestation than m vlrgm rats In humans, a greater reduction m forearm flow was observed m late pregnant than m nonpregnant or early pregnant women durmg mfuslon of L-NMA mto the brachlal artery *' Therefore, it appears that NO plays an important role m gestational dilation and decreased blood pressure durmg late stages of pregnancy but not dunng early or mid pregnancy Other mvestlgators, however, reported that the pressor responses to NO synthesis mhlbltlon m late pregnant and nonpregnant rats were not statlstlcally different '*** A maJor cause of the discrepancy between the results of these stu&es could be the doses used m the previous studies, which were high enough to cause marked hemodynamlc changes m both vlrgm and pregnant rats Multiple mechanisms have been proposed to explain enhanced systemic vasoconstnctlon and accentuated artenal pressure response to NO synthesis blockade m pregnant rats Edwards et alz3 recently reported that long-term NO synthesis mhlbltlon during mid to late gestation causes sustained hypertension and elevated levels ofplasma ET-l However, whether elevated ET-l levels are a cause of increased blood pressure or a consequence of the endothehal Injury caused by hypertension due to NO synthesis blockade 1s still unclear Another possible mechanism 1s that NO synthesis blockade m pregnant rats unmasks of the vasoconstnctor effects of clrculatmg ANG II, which 1s known to be elevated during pregnancy ' Whether increased vascular smooth muscle tone during chronic NO synthesis mhlbltlon m pregnant rats 1s due to a direct effect of reduced NO avallablhty or mdlrectly due to enhanced actlvlty of endogenous vasoconstnctors 1s still unclear and requires further mvestlgatlon
In addition to the peripheral vasoconstnctor effects of NO synthesis mhlbltlon m pregnant rats, we observed a significant decrease m RBF and increase m RVR that were greater m pregnant than m vrrgm rats NO has been previously shown to play an important role m the control of renal hemodynamlcs m the rat "" A possible role for NO m mediating the gestatlonal increases m renal blood flow 1s supported by studies by Danielson and Conrad,'" who reported that acute blockade of NO synthesis abrogates the renal vasodllatlon and hyperfiltratlon m pregnant rats The same group of mvestlgators," however, demonstrated that chronic blockade of NO (for 48 hours) failed to prevent the renal vasodllatlon during midgestation m rats mamly because of the compensatory mcrease m renal prostaglandms, since the vasodllatlon was prevented by meclofenamate The difference between these results and the present study may be due to the gestatlonal age when rats were examined or the dose, route, and duration of admmlstratlon of L-NAME Although the mechanism through which chronic NO mhlbltlon increases renal vascular smooth muscle tone 1s unknown, it 1s unlikely that this effect 1s mediated through overexpresslon or increased sensltlvlty of endogenous vasoconstnctors, since we recently reported that L-NAME-treated pregnant rats exhibited the same degree of renal vascular response to exogenously adnumstered ANG II as control pregnant rats *' Therefore, It appears that NO may play an Important role m me&atmg the gestatlonal increases m RBF, further mvestlgatlon 1s required to elucidate the mechamsms through which NO mediates renal vasotiatlon m pregnant rats
We also observed a reduction m blood flow to other organs, mcludmg the heart, lungs, hver, and skeletal muscles, confirmmg the importance of NO m regulating regonal blood flow dunng pregnancy NO has been previously reported to play an important role m long-term regulation of regional blood flow m vlrgm rats '* However, the state of NO production and its role m regulating regional blood flow dunng pregnancy have been studied mostly by using m vitro preparations Using m situ blood-perfused mesenterlc vessels, Chu and Bellm" reported a comparable potentlatlon of basal perfusion pressure and vascular reactivity to L-NNA m late pregnant and nonpregnant rats In Isolated mesentenc vessels, the vasoconstnctor response to phenylephrme was attenuated m late pregnant rats compared with nonpregnant rats, and L-NAME"' or L-NNA3' caused a twofold potentlatlon of the vasoconstnctor response m both groups In isolated hmdhmb preparations, vascular reactivity to ANG II, but not to NE, was attenuated m late pregnant rats and was enhanced by LNMA to nonpregnant levels j2 Although these data support our observation that NO does not play a role m regulating mesenterlc blood 5ow m pregnant rats, the pathological slgmficance of NO m mediating the flow alterations to other vascular beds still needs to be investigated Dunng the third trimester, a dramatic increase m blood flow to the uterus and placenta occurs to fulfill the nutritional needs of the rapidly growing fetus ' Recent studies have presented evidence that NO production Increases not only systemically durmg pregnancy but also m the uterine arteries m different anunal species "' Total nitrite production and cGMP levels are markedly elevated m rat uterine tissue during late gestation " Furthermore, calcium-dependent NO synthase activity has been shown to be elevated during pregnancy m guinea pig utenne artenes 94 A recent m vitro study has also demonstrated that the basal or activated endothehal-derived vasodllatlon IS augmented m uterine arteries of late pregnant compared with nonpregnant rats, mainly because of enhanced release of NO 's On the basis of these and other studies, it has been proposed that dlmmlshed NO synthesis m the uteroplacental clrculatlon will cause a reduction m placental perfuslon Surpnsmgly, we did not observe a decrease m uterine or placental blood flow after chronic NO synthesis blockade m pregnant rats In fact, uteroplacental flow tended to be higher m L-NAME-treated pregnant rats than m controls This observation could be explained by different mechamsms First, chronic L-NAME admmlstratlon could induce the expression of mduclble NO synthase, an enzyme that 1s known to produce a large amounts of NO and 1s less susceptible to mhlbltlon by L-NAME "" Second, since placental vessels lack the autoregulation, it 1s possible that the increased systemic arterial pressure m L-NAME-treated pregnant rats 1s transmitted to the placental clrculatlon, overcommg the lack of vasodllatlon due to NO deficiency Third, it 1s possible that a compensatory mechamsm 1s present m the placenta to mamtam placental perfusion by increasing synthesis (or enhancing the tissue sensltlvlty) of other vasodllators such as prostaglandms This explanation 1s supported by recent studies demonstrating that pregnancy 1s associated with a twofold to threefold increase m uterine artery PG12 from both the endothehum and vascular smooth muscle Furthermore, alterations m baqal uterine CAMP production are related directly to alterations m PG,2 production, and NO synthesis blockade does not alter either CAMP or PG12 production 's3') Further regional 5ow studies using combined NO and prostaglandm blockade or servocontrolled utenne perfusion pressure may be needed to clarify this point In summary, we confirm our previous observations that chronic NO synthesis mhlbltlon dunng mid to late gestation m rats 1s associated with a slgmficantly greater increase m arterial pressure than m vlrgm rats Chronic NO synthesis mhlbltlon m pregnant rats was also associated with significant reduction m cardiac output and an increase m total penpheral resistance L-NAME also caused slgmficant reductions m blood flow to the kidneys, heart, lungs, hver, and skeletal muscles m pregnant rats The changes m systemic and regonal hemodynamlcs m response to NO synthesis mhlbltlon m vqm rats either were not observed or were slgmficantly less than m pregnant rats The results of this study indicate that NO plays a role m mediating the alterations m systemic hemodynanucs and regonal flow m late pregnant rats
